Inventaire - dine venner og fællesskaber er dit bedste bibliotek

A case study of a long-term glioblastoma survivor with unmethylated MGMT and hypermutated genotype.

forfatter

Toni R. Jue

Kerrie L McDonald

udgivet i: Cold Spring Harbor molecular case studies

dato for udgivelse: 2019-06-03

main subject: glioblastoma multiforme

Cites articles 45

Date

Titel

Forfattere

2019-01-07

Hypermutagenesis in untreated adult gliomas due to inherited mismatch mutations

Jason K Sa
2018-12-18

Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer

P. Andrew Futreal
2018-12-27

High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
2017-08-01

Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy
2017-06-01

First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer

Enriqueta Felip, George R Blumenschein, Hossein Borghaei
2017-07-01

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment

Nikunj Satani, Florian Muller, Hoon Kim, Massimo Squatrito, Ana C. deCarvalho, Tom Mikkelsen, Ronald A. DePinho, Joanna J Phillips, Qianghu Wang, Lisa Scarpace, Sali Lyu, Floris Barthel, Emmanuel Martinez-Ledesma, Charles-Etienne Gabriel Sauvé, Adriana Olar, Gaetano Finocchiaro, Mitchel S Berger, Konrad Gabrusiewicz, Eskil Eskilsson, Erik P Sulman, Roel G W Verhaak
2017-08-23

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

Razelle Kurzrock
2017-10-26

POLE somatic mutations in advanced colorectal cancer.

Manuela Pinheiro, Ana Peixoto, Manuel R. Teixeira, Joana Guerra, Catarina Santos, Patrícia Rocha, Carla Pinto, Isabel Veiga
2017-11-20

ClinVar: improving access to variant interpretations and supporting evidence.

George Riley, Donna R. Maglott, Melissa Landrum
2016-02-22

DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution

Javier Herrero, Nicholas McGranahan, Charles Swanton
2016-02-22

The challenges associated with molecular targeted therapies for glioblastoma

Toni R. Jue
2016-06-06

The Ensembl Variant Effect Predictor

William M McLaren, Sarah E. Hunt, Paul Flicek, Fiona Cunningham, Anja Thormann, Laurent Gil, Harpreet Singh Riat, Graham R. S. Ritchie
2016-10-01

The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy

Sung-Min Ahn, Sung-Min Chun
2016-09-28

Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy

Elaine Mardis, Edward F Chang
2015-02-03

Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution

Carrie Sougnez, Gad Getz, Stacey Gabriel, Eric Lander, Lynda Chin, Florian Muller, Hoon Kim, Matthew Meyerson, Tom Mikkelsen
2015-03-03

Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis

Koray Özduman, Caner Caglar, Tanyeri Barak, Suleyman Coskun, M Necmettin Pamir, Katsuhito Yasuno, Chris Sander
2015-02-13

PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors

Christina K. Yung, Lincoln Stein, Quaid D Morris
2015-06-25

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Bert Vogelstein, Albert de la Chapelle, Bjarne Bartlett, Kenneth W Kinzler, Ralph H. Hruban, Laura D Wood, James R Eshleman, Todd S Crocenzi, James J Lee, Richard M Goldberg, Drew M Pardoll, Luis Alberto Diaz Jr, Nickolas Papadopoulos, Shibin Zhou, Ross C Donehower, Aleksandra D Eyring, Brandon S Luber, Dan Laheru, Janis M Taube, Toby Cornish, Feriyl Bhaijee
2015-09-01

Spatiotemporal Evolution of the Primary Glioblastoma Genome.

Byung Sup Kim
2015-12-08

Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications

Richard J Shaw, Anthony J Cox, Christopher T Saunders
2014-05-16

POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium

Martin Köbel, Gregg Nelson
2014-08

SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution

Elaine Mardis, William Schierding, Obi Griffith, Timothy A. Graubert, Malachi Griffith, Richard K. Wilson
2013-03-24

DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer

David N Church, Claire Palles, Enric Domingo, Jenny Taylor, Ian Tomlinson
2013-03-29

Cancer genome landscapes

Bert Vogelstein, Kenneth W Kinzler, Victor Velculescu, Luis Alberto Diaz Jr, Nickolas Papadopoulos, Shibin Zhou
2013-03-29

MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features

Fan Wang
2013-06-01

The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome
2013-08-22

Signatures of mutational processes in human cancer

Jessica Zucman-Rossi, Stian Knappskog, Anne-Lise Børresen-Dale, Marcin Imielinski, Keiran Raine, Carlos Caldas, Elli Papaemmanuil, Jon Teague, Anne Vincent-Salomon, Michael Stratton, P. Andrew Futreal, Sunil R Lakhani, Matthew Meyerson, Barbara Hutter, Marcel Kool, Stefan M. Pfister, Paul A Northcott, Serena Nik-Zainal, David T. W. Jones, Peter F. Stadler, Ralf Küppers, David Langenberger, Helen Davies, Xose S. Puente, Rafael Valdés-Mas
2013-10-01

From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline

Stacey Gabriel, David Altshuler, Eric Banks, Mark DePristo, Ami Levy Moonshine, Khalid Shakir, Chris Hartl, Ryan Poplin
2012-05-10

Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs
2012-06-26

An alternative pathway in colorectal carcinogenesis based on the mismatch repair system and p53 expression in Korean patients with sporadic colorectal cancer
2012-06-12

Novel survivin inhibitor YM155 elicits cytotoxicity in glioblastoma cell lines with normal or deficiency DNA-dependent protein kinase activity
2012-09-10

The T genotype of the MGMT C>T (rs16906252) enhancer single-nucleotide polymorphism (SNP) is associated with promoter methylation and longer survival in glioblastoma patients

Jake Olivier

Artikel - wd:Q64969067

Welcome to Inventaire

dit venne- og fællesskabs bibliotek

vil du vide mere